MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0305734

Медицинская библиотека · PloS one · 2024

Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study.

Akter Mariya, Roknuzzaman A S M, Shahriar Mohammad, Islam Sardar Mohammad Ashraful, Ahmed Bhuiyan Mohiuddin, Qusar M M A Shalahuddin, Kabir Eva Rahman, Islam Rabiul

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Major depressive disorder (MDD) is a common and debilitating mental illness characterized by persistent feelings of sadness, hopelessness, and a lack of interest in daily activities. The objective of this study was to investigate whether levels of macrophage inflammatory protein-1β (MIP-1β) and macrophage chemoattractant protein-2 (MCP-2) in the blood were associated with the pathophysiology and development of MDD compared to healthy controls (HCs).

METHODS

This case-control study was conducted involving 50 MDD patients and 38 HCs. We performed a comprehensive assessment to match age, sex, BMI, and socio-demographic profile between the groups. The study excluded participants with chronic infection, inflammatory diseases, coexisting psychiatric disorder, history of liver and kidney diseases, and individuals who are under antipsychotic medications. A professional psychiatrist diagnosed MDD patients and evaluated HCs based on the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) criteria. The severity of depression was assessed using the Hamilton Depression (Ham-D) rating scale. Commercially available enzyme-linked immunosorbent assay (ELISA) kits were used to quantify the serum MIP-1β and MCP-2 levels.

RESULTS

The results indicated elevated serum MIP-1β levels (207.73±24.24 pg/ml) in MDD patients compared to HCs (58.77±9.14 pg/ml). This difference in concentration is positively correlated with severity of disease symptoms (r = 0.451; p<0.001). Similarly, the levels of MCP-2 were found to be elevated in patients compared to controls (143.61±19.92 vs. 56.84±4.02 pg/ml; p = 0.003), with a positive correlation with the Ham-D scores (r = 0.373; p = 0.004).

CONCLUSION

According to this study, elevated levels of MIP-1β and MCP-2 may be associated with the pathophysiology and development of MDD. These increased serum MIP-1β and MCP-2 levels could be used as risk assessment tools for MDD. The present findings urge further research and the development of therapeutic and diagnostic approaches for depression.

Для цитирования: Akter Mariya, Roknuzzaman A S M, Shahriar Mohammad, Islam Sardar Mohammad Ashraful, Ahmed Bhuiyan Mohiuddin, Qusar M M A Shalahuddin, Kabir Eva Rahman, Islam Rabiul. Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study.. PloS one. 2024. DOI: 10.1371/journal.pone.0305734.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.